Newcastle disease virus research: pioneering scientists, landmark discoveries, and virological innovations
Veterinary Research Communications · 2027
DOI: 10.1007/s11259-026-11585-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Veterinary Research Communications, 2027. Verfasst von Aziz Ul-Rahman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Veterinary and Animal Sciences, MNS University of Agriculture, Multan, 60000, Pakistan. drazizangel@gmail.com. Hauptthemen laut MEDLINE: Newcastle disease virus, Newcastle Disease, Poultry Diseases. Die Arbeit nennt 134 Literaturangaben.
Abstract (Originalsprache)
Newcastle disease (ND) has been recognized for a century as one of the most consequential viral diseases of poultry, and its scientific history provides a distinctive example of how sustained investigation of a single pathogen can drive advances across veterinary medicine, virology, immunology, epidemiology, molecular biology, vaccinology, and biotechnology. The severe outbreaks reported in Java, Indonesia, and Newcastle-upon-Tyne, England, during 1926 marked the beginning of the recognized scientific history of ND and initiated an international research effort that progressed from disease recognition and experimental characterization to diagnostics, vaccination, molecular pathogenesis, and genomic epidemiology. During the 1940s and 1950s, investigations of viral propagation, antigenicity, pathogenicity, and attenuation established the foundations of live and inactivated vaccination. From the 1960s onward, molecular investigations progressively elucidated the determinants of ND virus (NDV) replication, protein processing, and virulence, particularly the role of the fusion-protein cleavage site. The emergence of nucleotide sequencing and phylogenetic analysis during the 1980s and 1990s subsequently transformed strain characterization and provided the foundations for molecular epidemiology and genotype classification. Complete-genome sequencing and the establishment of reverse-genetics systems in the late 1990s further transformed NDV from an organism studied primarily through observation and isolation into a genetically tractable experimental system. Subsequent international efforts standardized NDV genotype nomenclature and enabled increasingly detailed analyses of viral evolution and geographic dissemination. In parallel, NDV research expanded beyond conventional disease control into recombinant vaccine development, systems-level host–virus studies, molecular diagnostics, and oncolytic virotherapy. This historical perspective traces these major scientific transitions from 1926 to 2026, emphasizing the investigators, experimental systems, conceptual advances, and technological innovations that collectively transformed NDV research from disease recognition into a multidisciplinary molecular and translational fields.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Veterinary and Animal Sciences, MNS University of Agriculture, Multan, 60000, Pakistan. drazizangel@gmail.com.
- Faculty of Veterinary Medicine, Universitas Brawijaya, Malang, 65151, Indonesia. drazizangel@gmail.com.
- Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster, LA1 4YW, UK.
ORCID-Profile: Aziz Ul-Rahman
Zitieren
APA
Ul-Rahman, A., & Munir, M. (2027). Newcastle disease virus research: pioneering scientists, landmark discoveries, and virological innovations. Veterinary Research Communications. https://doi.org/10.1007/s11259-026-11585-7
Vancouver
Ul-Rahman A, Munir M. Newcastle disease virus research: pioneering scientists, landmark discoveries, and virological innovations. Veterinary Research Communications. 2027. doi:10.1007/s11259-026-11585-7
BibTeX
@article{UlRahman2027,
author = {Ul-Rahman, Aziz and Munir, Muhammad},
title = {Newcastle disease virus research: pioneering scientists, landmark discoveries, and virological innovations},
journal = {Veterinary Research Communications},
year = {2027},
doi = {10.1007/s11259-026-11585-7}
}
EUVIMED